Audrey’s research, funded by the Oxford Cancer Immuno-Oncology Network (OCION), is examining the relationship between the immune response triggered in cancer and atherosclerosis.
‘Anti-cancer treatments which aim at awakening immune responses, called checkpoint blockade, further increase the risk of developing cardiovascular diseases, highlighting the role of our immune system in both cancer and atherosclerosis,’ explains Audrey in an interview with OCION. The long-term goal is to identify ways to target the immune system to induce anti-cancer responses without increasing the likelihood of developing cardiovascular diseases.
Audrey recently talked to OCION about her work and the future of her research. You can read the full interview on the Oxford Cancer website.